Coloplast Crecimiento futuro
Future controles de criterios 3/6
Se prevé un crecimiento anual de los beneficios y los ingresos de Coloplast de 12.9% y 7.8% por año respectivamente. Se prevé que el BPA crezca en un 13.2% al año. Se espera que la rentabilidad financiera sea de 35.2% en 3 años.
Información clave
12.9%
Tasa de crecimiento de los beneficios
13.2%
Tasa de crecimiento del BPA
| Crecimiento de los beneficios de Medical Equipment | 18.6% |
| Tasa de crecimiento de los ingresos | 7.8% |
| Rentabilidad financiera futura | 35.1% |
| Cobertura de analistas | Good |
| Última actualización | 18 Nov 2024 |
Actualizaciones recientes sobre el crecimiento futuro
Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08
Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09Recent updates
Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 13Earnings Update: Coloplast A/S (CPH:COLO B) Just Reported Its Annual Results And Analysts Are Updating Their Forecasts
Nov 08Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Oct 18Coloplast A/S Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 23Are Investors Undervaluing Coloplast A/S (CPH:COLO B) By 38%?
Aug 22Subdued Growth No Barrier To Coloplast A/S' (CPH:COLO B) Price
Jul 17These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jun 29Coloplast's (CPH:COLO B) Solid Earnings May Rest On Weak Foundations
May 21Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of DKK5.00
May 10Analyst Estimates: Here's What Brokers Think Of Coloplast A/S (CPH:COLO B) After Its Interim Report
May 09A Look At The Fair Value Of Coloplast A/S (CPH:COLO B)
Apr 26There's Reason For Concern Over Coloplast A/S' (CPH:COLO B) Price
Apr 08Is Coloplast (CPH:COLO B) A Risky Investment?
Mar 21Estimating The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Jan 09Coloplast A/S' (CPH:COLO B) Price Is Out Of Tune With Earnings
Dec 22These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 04Coloplast (CPH:COLO B) Strong Profits May Be Masking Some Underlying Issues
Nov 16A Look At The Intrinsic Value Of Coloplast A/S (CPH:COLO B)
Sep 30Is Coloplast (CPH:COLO B) A Risky Investment?
Jun 28Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 18% Below Its Share Price
Jun 10Coloplast (CPH:COLO B) Seems To Use Debt Quite Sensibly
Mar 22Coloplast A/S' (CPH:COLO B) Intrinsic Value Is Potentially 25% Below Its Share Price
Mar 01These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Dec 14Coloplast's (CPH:COLO B) Upcoming Dividend Will Be Larger Than Last Year's
Nov 26Here's Why We Think Coloplast A/S' (CPH:COLO B) CEO Compensation Looks Fair for the time being
Nov 25Coloplast's (CPH:COLO B) Shareholders Will Receive A Bigger Dividend Than Last Year
Nov 11With EPS Growth And More, Coloplast (CPH:COLO B) Makes An Interesting Case
Oct 25Estimating The Fair Value Of Coloplast A/S (CPH:COLO B)
Aug 26These 4 Measures Indicate That Coloplast (CPH:COLO B) Is Using Debt Reasonably Well
Jul 27Here's Why We Think Coloplast (CPH:COLO B) Is Well Worth Watching
Jul 12Is There An Opportunity With Coloplast A/S' (CPH:COLO B) 45% Undervaluation?
May 23Coloplast (CPH:COLO B) Is Due To Pay A Dividend Of kr.5.00
May 08Previsiones de crecimiento de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Flujo de caja libre | Flujo de caja operativo | Núm. de analistas medio |
|---|---|---|---|---|---|
| 9/30/2027 | 34,540 | 7,522 | 7,366 | 8,804 | 13 |
| 9/30/2026 | 31,700 | 6,666 | 6,456 | 7,890 | 20 |
| 9/30/2025 | 29,277 | 5,746 | 5,508 | 6,844 | 17 |
| 9/30/2024 | 27,030 | 5,052 | 1,420 | 2,766 | N/A |
| 6/30/2024 | 26,303 | 4,967 | 1,313 | 2,599 | N/A |
| 3/31/2024 | 25,526 | 4,965 | 1,053 | 2,278 | N/A |
| 12/31/2023 | 25,001 | 4,868 | 4,285 | 5,527 | N/A |
| 9/30/2023 | 24,500 | 4,783 | 2,985 | 4,226 | N/A |
| 6/30/2023 | 24,333 | 4,784 | 3,226 | 4,485 | N/A |
| 3/31/2023 | 24,074 | 4,801 | 3,663 | 4,894 | N/A |
| 12/31/2022 | 23,515 | 4,626 | 3,246 | 4,455 | N/A |
| 9/30/2022 | 22,579 | 4,706 | 3,964 | 5,099 | N/A |
| 6/30/2022 | 21,620 | 4,781 | 3,894 | 4,913 | N/A |
| 3/31/2022 | 20,606 | 4,746 | 3,735 | 4,712 | N/A |
| 12/31/2021 | 19,857 | 4,896 | 4,272 | 5,209 | N/A |
| 9/30/2021 | 19,426 | 4,825 | 3,324 | 5,290 | N/A |
| 6/30/2021 | 18,916 | 4,561 | 3,102 | 5,023 | N/A |
| 3/31/2021 | 18,500 | 4,304 | 3,162 | 5,077 | N/A |
| 12/31/2020 | 18,570 | 4,241 | 3,003 | 4,941 | N/A |
| 9/30/2020 | 18,544 | 4,197 | 3,828 | 4,759 | N/A |
| 6/30/2020 | 18,572 | 3,949 | 3,876 | 4,842 | N/A |
| 3/31/2020 | 18,752 | 4,020 | 3,872 | 4,764 | N/A |
| 12/31/2019 | 18,330 | 3,974 | 3,833 | 4,615 | N/A |
| 9/30/2019 | 17,939 | 3,873 | 3,667 | 4,357 | N/A |
| 6/30/2019 | 17,555 | 4,119 | 3,599 | 4,161 | N/A |
| 3/31/2019 | 17,181 | 3,999 | 3,562 | 4,177 | N/A |
| 12/31/2018 | 16,815 | 3,896 | 3,522 | 4,126 | N/A |
| 9/30/2018 | 16,449 | 3,845 | 3,692 | 4,361 | N/A |
| 6/30/2018 | 16,195 | 3,816 | N/A | 4,370 | N/A |
| 3/31/2018 | 15,882 | 3,778 | N/A | 4,111 | N/A |
| 12/31/2017 | 15,728 | 3,791 | N/A | 4,004 | N/A |
| 9/30/2017 | 15,528 | 3,797 | N/A | 3,251 | N/A |
| 6/30/2017 | 15,287 | 3,211 | N/A | 2,994 | N/A |
| 3/31/2017 | 15,061 | 3,279 | N/A | 2,492 | N/A |
| 12/31/2016 | 14,780 | 3,264 | N/A | 2,653 | N/A |
| 9/30/2016 | 14,681 | 3,143 | N/A | 3,028 | N/A |
| 6/30/2016 | 14,563 | 1,297 | N/A | 3,081 | N/A |
| 3/31/2016 | 14,417 | 1,028 | N/A | 3,568 | N/A |
| 12/31/2015 | 14,264 | 927 | N/A | 3,320 | N/A |
| 9/30/2015 | 13,909 | 899 | N/A | 3,337 | N/A |
| 6/30/2015 | 13,502 | 3,162 | N/A | 3,119 | N/A |
| 3/31/2015 | 13,096 | 3,241 | N/A | 3,015 | N/A |
| 12/31/2014 | 12,666 | 2,407 | N/A | 3,193 | N/A |
| 9/30/2014 | 12,428 | 2,390 | N/A | 3,149 | N/A |
| 6/30/2014 | 12,184 | 2,298 | N/A | 3,177 | N/A |
| 3/31/2014 | 12,008 | 2,220 | N/A | 3,074 | N/A |
| 12/31/2013 | 11,833 | 2,874 | N/A | 3,270 | N/A |
Previsiones de crecimiento futuro de los analistas
Ingresos vs. Tasa de ahorro: El pronóstico de crecimiento de los beneficios (12.9% al año) de COLO B es superior a la tasa de ahorro (1.2%).
Beneficios vs. Mercado: Se prevé que los beneficios (12.9% al año) de COLO B crezcan más rápidamente que el mercado Danish (11.6% al año).
Beneficios de alto crecimiento: Se prevé que los beneficios de COLO B crezcan, pero no significativamente.
Ingresos vs. Mercado: Se prevé que los ingresos (7.8% al año) de COLO B crezcan más despacio que el mercado de Danish (10% al año).
Ingresos de alto crecimiento: Se prevé que los ingresos 7.8% al año) de COLO B crezcan más despacio que 20% al año.
Previsiones de crecimiento de los beneficios por acción
Rentabilidad financiera futura
ROE futura: Se prevé que la rentabilidad financiera de COLO B sea alta dentro de 3 años (35.2%)